Aggrastat (tirofiban) dosing, indications, interactions, adverse ...
Studies with intravenous doses up to 5 mg/kg/day (about 5 and 13 times maximum recommended daily human dose for rat and rabbit, respectively, compared on a body surface area basis) have revealed... 展开
abrocitinibabrocitinib and tirofiban both increase anticoagulation. Contraindicated. Antiplatelet drugs, except for low-dose aspirin (=81 mg qDay), … 展开
- 1. acalabrutinibacalabrutinib increases effects of tirofiban by anticoagulation. M…
- 2. aspirinaspirin, tirofiban.Either increases toxicity of the other by pharmacodynami…
- 3. aspirin/citric acid/sodium bicarbonateaspirin/citric aci… 展开
- 1. antithrombin alfaantithrombin alfa, tirofiban.Either increases effects of the o…
- 2. antithrombin IIIantithrombin III, tirofiban.Either increases effects of the o…
- 3. apixabantirofiban and apixaban both increase anticoagulation. A… 展开
Aggrastat Uses, Side Effects & Warnings - Drugs.com
2024年2月8日 · What is Aggrastat? Aggrastat is used to prevent blood clots or heart attack in people with severe chest pain or other conditions, and in those who are undergoing a …
- 预计阅读时间：5 分钟
INDICATIONS AND USAGE AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events (combined endpoint of death, myocardial infarction, or refractory …
Dosing and Administration | Formulas and Calculators | Aggrastat ...
Dosing and Administration The recommended dosage is 25 mcg/kg administered intravenously within 5 minutes and then 0.15 mcg/kg/min for up to 18 hours. In patients with creatinine …
CLINICAL PHARMACOLOGY Mechanism of Action AGGRASTAT is a reversible antagonist of fibrinogen binding to the GP IIb/IIIa receptor, the major platelet surface receptor involved in …
CLINICAL PHARMACOLOGY Mechanism of Action AGGRASTAT is a reversible antagonist of fibrinogen binding to the GP lIb/lIla receptor, the major platelet surface receptor involved in …
- 其他用户还问了以下问题
2 DOSAGE AND ADMINISTRATION Administer intravenously 25 mcg/kg within 5 minutes and then 0.15 mcg/kg/min (or 0.075 mcg/kg/min for patients with serum creatinine ≤60 mL/min), for …
- [PDF]
Pr AGGRASTAT®
2018年10月7日 · AGGRASTAT® (tirofiban hydrochloride) is indicated for the: management of adult patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) including patients …
Tirofiban - Wikipedia
Tirofiban, sold under the brand name Aggrastat, is an antiplatelet medication. It belongs to a class of antiplatelets named glycoprotein IIb/IIIa inhibitors.
Tirofiban Monograph for Professionals - Drugs.com
2024年9月9日 · Regarding choice of GP IIb/IIIa-receptor inhibitor in patients undergoing PCI, IV abciximab, “double-bolus” IV eptifibatide, and high-dose tirofiban by direct IV injection all …
IV Aggrastat 的相关搜索
- 某些结果已被删除
